Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives

Diabetes is the leading cause of chronic and end stage kidney disease globally. Despite recent advances in therapies for diabetic kidney disease (DKD), there remains a critical need for additional options to improve renal and cardiovascular outcomes. Mineralocorticoid overactivation contributes to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh, Aisha, Ray, Justina, Campbell, Kirk N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346301/
https://www.ncbi.nlm.nih.gov/pubmed/35937973
http://dx.doi.org/10.2147/TCRM.S325916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346301/
https://www.ncbi.nlm.nih.gov/pubmed/35937973
http://dx.doi.org/10.2147/TCRM.S325916

Ejemplares similares